Gruber James R.
SEC insider (Form 3/4/5 filer). CIK 0001923165. Chief Financial Officer at Eton Pharmaceuticals, Inc. (ETON). 9 reported Form 4/5 transactions since Sep 2024; latest on Jan 14, 2026. Located in DEERPARK, IL.
Companies Gruber James R. has filed insider reports for
- Eton Pharmaceuticals, Inc. (ETON): Officer, Chief Financial Officer
Gruber James R.
CIK: 0001923165
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Eton Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jan 14, 2026ETON
Eton Pharmaceuticals, Inc.
Tax PaymentDirect2.3K shares at avg. $15.47$35K - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
25.9K shares- - Jan 12, 2026ETON
Eton Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
40.7K shares- - Dec 12, 2025ETON
Eton Pharmaceuticals, Inc.
Tax PaymentDirect4.5K shares at avg. $16.99$77K - Dec 11, 2025ETON
Eton Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
5.5K shares- - Aug 20, 2025ETON
Eton Pharmaceuticals, Inc.
SaleDirect2.6K shares at avg. $16.02$42K - Aug 19, 2025ETON
Eton Pharmaceuticals, Inc.
SaleDirect39.1K shares at avg. $16.16$632K - Jan 3, 2025ETON
Eton Pharmaceuticals, Inc.
AwardDirectEmployee Stock Option (Right to Buy)
38.6K shares- - Jan 3, 2025ETON
Eton Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
25.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 14, 2026 | ETON Eton Pharmaceuticals, Inc. | Tax Payment | 2,293 | $15.47 | $35,473 | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Restricted Stock Units | 25,856 | - | - | Direct |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | Award Employee Stock Option (Right to Buy) | 40,655 | - | - | Direct |
| Dec 12, 2025 | ETON Eton Pharmaceuticals, Inc. | Tax Payment | 4,542 | $16.99 | $77,169 | Direct |
| Dec 11, 2025 | ETON Eton Pharmaceuticals, Inc. | Award Restricted Stock Units | 5,502 | - | - | Direct |
| Aug 20, 2025 | ETON Eton Pharmaceuticals, Inc. | Sale | 2,631 | $16.02 | $42,149 | Direct |
| Aug 19, 2025 | ETON Eton Pharmaceuticals, Inc. | Sale | 39,082 | $16.16 | $631,565 | Direct |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | Award Employee Stock Option (Right to Buy) | 38,621 | - | - | Direct |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | Award Restricted Stock Units | 25,876 | - | - | Direct |
1-9 of 9 transactions